Vanilloid receptor agonists potentiate the in vivo local anesthetic activity of percutaneously injected site 1 sodium channel blockers

DS Kohane, Y Kuang, NT Lu, R Langer… - The Journal of the …, 1999 - pubs.asahq.org
Background Capsaicin, the pungent ingredient in chili peppers, is a vanilloid with noxious
and analgesic effects that inhibits tetrodotoxin-resistant sodium currents. Because …
被引用次数：47 相关文章

Vanilloid receptor agonists potentiate the in vivo local anesthetic activity of percutaneously injected site 1 sodium channel blockers.

DS Kohane, Y Kuang, NT Lu, R Langer… - …, 1999 - europepmc.org
Background Capsaicin, the pungent ingredient in chili peppers, is a vanilloid with noxious
and analgesic effects that inhibits tetrodotoxin-resistant sodium currents. Because …

[引用][C] Vanilloid receptor agonists potentiate the in vivo local anesthetic activity of percutaneously injected Site 1 sodium channel blockers

DS KOHANE, YU KUANG, NT LU… - Anesthesiology …, 1999 - pascal-francis.inist.fr
Vanilloid receptor agonists potentiate the in vivo local anesthetic activity of percutaneously
injected Site 1 sodium channel blockers CNRS Inist Pascal-Francis CNRS Pascal and …

Vanilloid receptor agonists potentiate the in vivo local anesthetic activity of percutaneously injected site 1 sodium channel blockers

DS Kohane, Y Kuang, NT Lu, R Langer… - …, 1999 - pubmed.ncbi.nlm.nih.gov
Background Capsaicin, the pungent ingredient in chili peppers, is a vanilloid with noxious
and analgesic effects that inhibits tetrodotoxin-resistant sodium currents. Because …

Vanilloid receptor agonists potentiate the in vivo local anesthetic activity of percutaneously injected site 1 sodium channel blockers

DS Kohane, Y Kuang, NT Lu, R Langer… - Anesthesiology, 1999 - hero.epa.gov
BACKGROUND: Capsaicin, the pungent ingredient in chili peppers, is a vanilloid with
noxious and analgesic effects that inhibits tetrodotoxin-resistant sodium currents. Because …

[引用][C] Vanilloid receptor agonists potentiate the in vivo local anesthetic activity of percutaneously injected Site 1 sodium channel blockers

DS KOHANE, YU KUANG, NT LU… - …, 1999 - Lippincott Williams & Wilkins